Apellis Pharmaceuticals (NASDAQ:APLS) Coverage Initiated at Piper Sandler
Research analysts at Piper Sandler began coverage on shares of Apellis Pharmaceuticals (NASDAQ:APLS – Get Free Report) in a note issued to investors on Friday, MarketBeat Ratings reports. The brokerage set a “neutral” rating and a $46.00 price target on the stock. Piper Sandler’s target price points to a potential upside of 17.20% from the […]
More Stories
PIMCO High Income Fund (NYSE:PHK) to Issue $0.05 Monthly Dividend
PIMCO High Income Fund (NYSE:PHK – Get Free Report) announced a monthly dividend on Tuesday, October 1st, NASDAQ reports. Investors...
PIMCO Municipal Income Fund Plans Monthly Dividend of $0.04 (NYSE:PMF)
PIMCO Municipal Income Fund (NYSE:PMF – Get Free Report) announced a monthly dividend on Tuesday, October 1st, NASDAQ reports. Stockholders...
Pyxis Tankers Inc. (NASDAQ:PXSAP) Plans $0.16 Monthly Dividend
Pyxis Tankers Inc. (NASDAQ:PXSAP – Get Free Report) declared a monthly dividend on Tuesday, October 1st, investing.com reports. Stockholders of...
Pimco Dynamic Income Opportunities Fund (NYSE:PDO) to Issue $0.13 Monthly Dividend
Pimco Dynamic Income Opportunities Fund (NYSE:PDO – Get Free Report) declared a monthly dividend on Tuesday, October 1st, NASDAQ reports....
ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN (NYSEARCA:CEFD) Plans Dividend Increase – $0.29 Per Share
ETRACS Monthly Pay 1.5X Leveraged Closed-End Fund Index ETN (NYSEARCA:CEFD – Get Free Report) announced a dividend on Wednesday, October...
PACS Group, Inc. (NYSE:PACS) Receives Consensus Rating of “Buy” from Analysts
PACS Group, Inc. (NYSE:PACS – Get Free Report) has received a consensus rating of “Buy” from the eight ratings firms...